Concepedia

Author

JP Lotz

Sorbonne Université

Also Known As

J Lotz, J P Lotz, J-P Lotz, J-P. Lotz, J. -P. Lotz, J. Lotz, J.-P. Lotz, J.P. Lotz, JP Lotz

44

Publications

342

Citations

7

H-Index

24

Concepts

All Affiliations

Sorbonne UniversitéHôpital TenonHôpital Saint-LouisKU LeuvenInstitut de Cancérologie de l'Ouest
JL

About

JP Lotz is an author at Sorbonne Université specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

277

2

Blood Transplantation

2

2

81

3

Cellular Therapies

2

2

81

4

Health Sciences

1

1

61

5

Cell Biology

1

1

61

JP Lotz

×

7

Publications

304

Citations

7

H-Index

YearCitations

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André,

Annals of Oncology

2013

101

Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations

Eléna Foïs, M Desmartin, Sonia Benhamida,

Bone Marrow Transplantation

2007

61

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE

Juliette Thariat, Thomas Schouman, A. Brouchet,

Annals of Oncology

2012

56

Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.

Christian Gisselbrecht, J.M. Extra, JP Lotz,

PubMed

1996

27

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

Christian Chabannon, Kenneth Cornetta, JP Lotz,

British Journal of Cancer

1998

25

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial

Saul Yanovich, Peggie Mitsky, Kenneth Cornetta,

Bone Marrow Transplantation

2000

20

1619O High clinical benefit rates of single agent pembrolizumab in selected rare sarcoma histotypes: First results of the AcSé Pembrolizumab study

Jean‐Yves Blay, Sylvie Chevret, Nicolas Penel,

Annals of Oncology

2020

14

Page 1